About this data
Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.
LY900014
- Company
- Eli Lilly and Company
- Mechanism
- Mechanism not yet reported
- Route
- Route not yet reported
- Recruiting trials
- None currently listed
Efficacy results: Not yet reported
No recruiting studies currently listed
See all studies for this drugData source: ClinicalTrials.gov · trial data as of Sep 11, 2026
Trial details
-
Completed NCT NCT02317575
A Study of LY900014 Formulations in Healthy Participants
Not yet reported Eli Lilly and Company 29 participants Est. completion 2015-09 1 site Stand-aloneOther conditions: Healthy VolunteersView official trial listing → -
Completed NCT NCT02525744
A Study of a New LY900014 Formulation in Healthy Participants
Not yet reported Eli Lilly and Company 24 participants Est. completion 2015-10 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02636361
A Study of Various Formulations of LY900014 in Healthy Participants
Not yet reported Eli Lilly and Company 26 participants Est. completion 2016-02 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02703324
A Study of LY900014 Formulation in Participants With Type 1 Diabetes Mellitus Using Insulin Pumps
Not yet reported Eli Lilly and Company 30 participants Est. completion 2016-08 1 site Stand-aloneOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT02703337
A Study of LY900014 in Participants With Type 2 Diabetes on Insulin Injection Therapy
Not yet reported Eli Lilly and Company 30 participants Est. completion 2016-08 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT02703350
A Study of LY900014 in Participants With Type 1 Diabetes on Insulin Injection Therapy
Not yet reported Eli Lilly and Company 30 participants Est. completion 2016-07 1 site Stand-aloneOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT02752087
A Study to Compare the Effects of a Test and Reference Formulation of LY900014 in Healthy Participants
Not yet reported Eli Lilly and Company 24 participants Est. completion 2016-05 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02770521
A Study of Treprostinil and a New Formulation of LY900014 in Healthy Japanese Participants
Not yet reported Eli Lilly and Company 23 participants Est. completion 2016-07 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02942654
A Study of LY900014 Formulation in Healthy Participants
Not yet reported Eli Lilly and Company 32 participants Est. completion 2016-12 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT03056456
A Study of LY900014 Administered in Participants With Type 1 Diabetes Using an Insulin Pump
Not yet reported Eli Lilly and Company 24 participants Est. completion 2017-06-19 2 sites Stand-aloneOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT03166124
A Study of LY900014 in Elderly and Younger Adult Participants With Type 1 Diabetes Mellitus
Not yet reported Eli Lilly and Company 80 participants Est. completion 2017-11-18 2 sites Stand-aloneOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT03214367
A Study of LY900014 in Participants With Type 1 Diabetes
Not yet reported Eli Lilly and Company 1392 participants Est. completion 2019-08-22 172 sites Stand-aloneOther conditions: Type 1 Diabetes MellitusView official trial listing → -
Completed NCT NCT03214380
A Study of LY900014 Compared to Insulin Lispro in Participants With Type 2 Diabetes
Not yet reported Eli Lilly and Company 933 participants Est. completion 2019-03-13 141 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT03232983
A Study of LY900014 Formulation at Different Injection Sites in Healthy Participants
Not yet reported Eli Lilly and Company 28 participants Est. completion 2017-11-09 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT03286751
A Comparative Study of LY900014 to Insulin Lispro (Humalog) in Healthy Participants
Not yet reported Eli Lilly and Company 42 participants Est. completion 2018-02-06 2 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT03305822
A Study of LY900014 in Participants With Type 2 Diabetes Mellitus
Not yet reported Eli Lilly and Company 38 participants Est. completion 2017-12-14 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT03334448
A Study to Compare 2 Formulations of LY900014 in Healthy Participants
Not yet reported Eli Lilly and Company 49 participants Est. completion 2018-03-15 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT03341299
A Comparative Study of LY900014 With Insulin Lispro (Humalog) in Participants With Type 1 Diabetes Mellitus
Not yet reported Eli Lilly and Company 36 participants Est. completion 2018-04-03 2 sites Stand-aloneOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT03341312
A Comparative Study of LY900014 With Insulin Lispro (Humalog) in Participants With Type 2 Diabetes Mellitus (T2DM)
Not yet reported Eli Lilly and Company 36 participants Est. completion 2018-03-31 2 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT03407118
A Study of LY900014 in Japanese Participants With Type 1 Diabetes Mellitus
Not yet reported Eli Lilly and Company 31 participants Est. completion 2018-07-12 1 site Stand-aloneOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT03433677
A Study of LY900014 and Insulin Lispro With an External Continuous Subcutaneous Insulin Infusion System in Adult Participants With Type 1 Diabetes
Not yet reported Eli Lilly and Company 49 participants Est. completion 2018-09-04 5 sites Stand-aloneOther conditions: Diabetes Type 1View official trial listing → -
Completed NCT NCT03449433
A Meal Test Study of LY900014 in Participants With Type 1 Diabetes Mellitus
Not yet reported Eli Lilly and Company 80 participants Est. completion 2018-08-14 1 site Stand-aloneOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT03465878
A Study of LY900014 in Participants With Type 1 Diabetes Mellitus
Not yet reported Eli Lilly and Company 56 participants Est. completion 2019-11-14 2 sites Stand-aloneOther conditions: Type 1 Diabetes MellitusView official trial listing → -
Completed NCT NCT03616977
Study to Compare 2 Formulations of LY900014 in Healthy Participants
Not yet reported Eli Lilly and Company 69 participants Est. completion 2018-10-19 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT03740919
A Study Comparing LY900014 to Insulin Lispro (Humalog) in Children and Adolescents With Type 1 Diabetes
Not yet reported Eli Lilly and Company 751 participants Est. completion 2021-07-02 111 sites Stand-aloneOther conditions: Type 1 Diabetes MellitusView official trial listing → -
Completed NCT NCT03760640
A Study of LY900014 in a Medtronic Pump
Not yet reported Eli Lilly and Company 42 participants Est. completion 2019-10-07 2 sites Stand-aloneOther conditions: Type1 Diabetes MellitusView official trial listing → -
Completed NCT NCT03830281
A Study Comparing LY900014 to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes Using Insulin Pump Therapy
Not yet reported Eli Lilly and Company 471 participants Est. completion 2020-01-06 83 sitesOther conditions: Type 1 Diabetes MellitusView official trial listing → -
Completed NCT NCT03952130
A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes
Not yet reported Eli Lilly and Company 354 participants Est. completion 2022-01-10 30 sites Stand-aloneOther conditions: Type 1 Diabetes MellitusView official trial listing → -
Completed NCT NCT03952143
A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 2 Diabetes
Not yet reported Eli Lilly and Company 628 participants Est. completion 2021-01-20 41 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT04049123
A Study of LY900014 in Healthy Chinese Participants
Not yet reported Eli Lilly and Company 15 participants Est. completion 2020-10-23 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT04276207
A Study of LY900014 Versus Insulin Lispro (Humalog) on High Blood Sugar in Participants With Type 1 Diabetes Who Use Insulin Pumps
Not yet reported Eli Lilly and Company 32 participants Est. completion 2020-08-10 1 site Stand-aloneOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT04585776
A Study of LY900014 and Insulin Degludec in Participants With Type 1 Diabetes
Not yet reported Eli Lilly and Company 31 participants Est. completion 2021-05-27 3 sites Stand-aloneOther conditions: Type 1 DiabetesView official trial listing → -
Completed NCT NCT04605991
A Study of Mealtime Insulin LY900014 in Participants With Type 2 Diabetes Using Continuous Glucose Monitoring (PRONTO-Time in Range)
Not yet reported Eli Lilly and Company 187 participants Est. completion 2022-02-04 32 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT05262387
A Study of LY900014 (Lyumjev) Versus Insulin Lispro (Humalog) in Participants With Type 1 Diabetes
Not yet reported Eli Lilly and Company 25 participants Est. completion 2023-03-07 1 siteOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT06370715
A Study of LY900014 in Adult Participants With Type 2 Diabetes Mellitus in India
Not yet reported Eli Lilly and Company 150 participants Est. completion 2025-09-02 12 sitesType 2 diabetesView official trial listing →
Efficacy history
Not yet reported.
Safety
Not yet reported.
Sources
Related On The Pen coverage
No related coverage yet.
This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.